Thomas R. Carper bought Revance Therapeutics, Inc. - Common Stock (RVNC)
Thomas R. Carper (D-DE), a U.S. Senator, has disclosed 1 trade in Revance Therapeutics, Inc. - Common Stock (RVNC) since 2023, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Thomas R. Carper bought $1,001 - $15,000 of Revance Therapeutics, Inc. - Common Stock (RVNC) on October 4, 2023. Since that trade, RVNC is up +0.00% against the S&P 500 up +80.19%, an outperformance of -80.19%.
Data updated
Thomas R. Carper's RVNC trades vs the price
RVNC is up +0.00% since Thomas R. Carper bought on October 4, 2023, versus +80.19% for the S&P 500.
Performance since this trade
All Thomas R. Carper RVNC trades
Thomas R. Carper & RVNC trading FAQ
Is it legal for Thomas R. Carper to trade Revance Therapeutics, Inc. - Common Stock (RVNC) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Revance Therapeutics, Inc. - Common Stock (RVNC), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Thomas R. Carper buy RVNC?
Thomas R. Carper disclosed a purchase of $1,001 - $15,000 of Revance Therapeutics, Inc. - Common Stock (RVNC) on October 4, 2023, according to public STOCK Act filings.
How has RVNC performed since Thomas R. Carper's trade?
Since Thomas R. Carper bought RVNC on October 4, 2023, the stock is up +0.00%, versus +80.19% for the S&P 500 over the same period, an outperformance of -80.19%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional RVNC trades?
Quantellect tracks every disclosed congressional trade in Revance Therapeutics, Inc. - Common Stock (RVNC) on the Revance Therapeutics, Inc. - Common Stock congressional trading page, which aggregates filings across all members of Congress.
Thomas R. Carper's RVNC tradesAll congressional filings for Revance Therapeutics, Inc. - Common StockThomas R. Carper's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.